Loading insider details...
Beta
Latest Form 4 (Jan 8, 2025): Sale of 727 ENTO shares, $465.28.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jan 8, 2025 | Entero Therapeutics, Inc. (ENTO) | Sale | 727 | $465.28 |
| Oct 10, 2024 | Entero Therapeutics, Inc. (ENTO) | Sale | 476 | $212.30 |
| Jul 3, 2024 | Entero Therapeutics, Inc. (ENTO) | Sale | 621 | $664.47 |
| Apr 3, 2024 | First Wave BioPharma, Inc. (FWBI) | Sale | 75 | $317.20 |
| Mar 19, 2024 | First Wave BioPharma, Inc. (FWBI) | Sale | 1,120 | $5.6K |
| Jan 17, 2024 | First Wave BioPharma, Inc. (FWBI) | Sale | 98 | $411.60 |
| Jan 4, 2024 | First Wave BioPharma, Inc. (FWBI) | Grant/Award | 12,614 | n/a |
| Oct 6, 2023 | First Wave BioPharma, Inc. (FWBI) | Sale | 1,676 | $486.04 |
| Jul 5, 2023 | First Wave BioPharma, Inc. (FWBI) | Sale | 1,977 | $3.0K |
| Apr 5, 2023 | First Wave BioPharma, Inc. (FWBI) | Sale | 1,975 | $4.9K |